ILMN
HealthcareIllumina, Inc.
$141.33
+$6.98 (+5.20%)
Jan 5, 2026
Price History (1Y)
Analysis
Illumina, Inc. is a leading company in the Healthcare sector and Diagnostics & Research industry, with a significant market presence as indicated by its market capitalization of $21.72 billion. The company employs approximately 9,870 individuals, reflecting its substantial scale. In terms of financial health, Illumina exhibits notable profitability metrics, including a gross margin of 68.4%, operating margin of 21.4%, and profit margin of 16.4%. Additionally, the company generates strong returns, with a return on equity (ROE) of 31.2% and return on assets (ROA) of 9.1%. The balance sheet reveals a debt-to-equity ratio of 108.19, while cash and debt levels stand at $1.28 billion and $2.58 billion, respectively. Illumina's valuation context is characterized by a price-to-earnings (P/E) ratio of 30.13 and forward P/E of 28.01. The company's revenue growth has been relatively stable over the past year, with a YoY increase of 0.4%, while earnings have experienced a significant decline of -77.8%. Dividend information is not available for Illumina, as indicated by a payout ratio of 0.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Illumina, Inc.
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Visit website →Key Statistics
- Market Cap
- $21.72B
- P/E Ratio
- 30.13
- 52-Week High
- $153.06
- 52-Week Low
- $68.70
- Avg Volume
- 1.72M
- Beta
- 1.41
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NMS
- Country
- United States
- Employees
- 8,970